SCHEMBL5835384

SCHEMBL5835384

CCN(CC)c1ccc(NC(=O)[C@]2(N(CC(C)C)C(=O)O)CCc3cc(Br)ccc3C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 5/20 0.45
KCNH2 Q12809 1/20 0.44
RAB9A P51151 4/20 0.37
MAPT P10636 4/20 0.37
NPC1 O15118 3/20 0.37
MAPK1 P28482 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
MEN1 O00255 3/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
POLB P06746 2/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
GFER P55789 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835479 1.00 GHSR (0.45) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835248 0.88 GHSR (0.49) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835661 0.88 GHSR (0.49) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835330 0.84 GHSR (0.41) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5834760 0.84 GHSR (0.41) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835333 0.84 GHSR (0.41) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5834764 0.84 GHSR (0.41) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835630 0.80 GHSR (0.61) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5836507 0.80 GHSR (0.61) GHSRKCNH2RAB9AMAPTNPC1
SCHEMBL5835552 0.79 GHSR (0.48) GHSRKCNH2RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885RAB9A 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.